ScienceDex / Researcher record
Feng, Hanping
- Fzata, Inc. (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $1,460,626 | 1 | #4,192 |
| 2018 | $1,170,960 | 1 | #6,137 |
| 2019 | $2,138,618 | 1 | #2,853 |
| 2020 | $2,154,339 | 1 | #816 |
| 2021 | $167,253 | 1 | #39,164 |
| 2022 | $1,008,708 | 1 | #9,659 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20181 record
- FY20191 record
- FY20201 record
- FY20211 record
- FY2022 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Feng, Hanping as a PI. Multi-PI records show the full award amount for context.
- 5R01AI132207-06R01Contact PIA Novel Humanized Tetra-specific Antibody against Clostridium difficile Infection$1Maward amount
Award organization
Organizations that administered FY2022 awards listing Feng, Hanping as a PI.
FY2022 award administered by Fzata, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardFzata, Inc.
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #4192
- 2017Entered Top 25% NationallyRanked #4192
- 2018$2M Cumulative Funding
- 2019R01 Grant Holder
- 2020$5M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #816
- 2020Entered Top 5% NationallyRanked #816